Are you attending the ABN next week? If, yes you may be interested in hearing a debate.
If you are free on Wednesday evening, the 9th May, and are attending the ABN in Birmingham please join the Neurology Academy to hear a debate on whether or not NHS England's proposed Treatment Algorithm for disease-modifying therapies in multiple sclerosis will achieve their aim of reducing the wide variation in DMT prescribing across England.
The Neurology Academy is an innovative education provider for clinicians, specialist nurses and professions allied to medicine. The training programs focus on both disease management and service transformation. Each priority condition is led by an Academic Faculty of practising clinicians who operate within a separate disease focussed Academy, for example, the MS Academy.
MS Academy ABN 2018 - Venue Hall 7
19:00: Assemble for drink, buffet and networking
19:30: Debate – The proposed new NHS England MS Prescribing Guidelines will stop the current wide variation in DMT prescribing across England (YES - David Paling / NO - Gavin Giovannoni).
20:15: Presentation about the Academy
20:30: Questions and depart
Please RSVP via this link.
Gavin Giovannoni & David Paling
Director & Strategic Director MS Academy
Labels: ABN, MS Academy